Janelle E. Stanton

Ms. Janelle E. Stanton


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
RHRajendran Harishkumar
Rajendran Harishkumar
Sakshi HansSakshi Hans
Sakshi Hans
JSJanelle E. Stanton
Janelle E. Stanton
Andreas GrabruckerAndreas Grabrucker
Andreas Grabrucker
Ronan LordanRonan Lordan
Ronan Lordan
Ioannis ZabetakisIoannis Zabetakis
Ioannis Zabetakis
Platelet-activating factor (PAF) is a lipid mediator that interacts with its receptor (PAF-R) to carry out cell signalling. However, under certain conditions the binding of PAF to PAF-R leads to the activation of pro-inflammatory and prothrombotic pathways that have been implicated in the onset and development of atherosclerotic cardiovascular diseases (CVD) and inflammatory diseases. Over the past four decades, research has focused on the identification and development of PAF-R antagonists that target these inflammatory diseases. Research has also shown that dietary factors such as polar lipids, polyphenols, and other nutrient constituents may affect PAF metabolism and PAF-R function through various mechanisms. In this review we focus on the inhibition of PAF-R and how this may contribute to reducing cardiovascular disease risk. We conclude that further development of PAF-R inhibitors and human studies are required to investigate how modulation of the PAF-R may prevent the development of atherosclerotic cardiovascular disease and may lead to the development of novel therapeutics.